Serotonin and hydroxyindolacetic acid levels in aqueous humor of patients with primary open-angle glaucoma

被引:0
作者
Ghanem, Asaad A. [1 ]
Mady, Salah M. [2 ]
Arafa, Lamiaa F. [3 ]
Elewa, Ahmed M. [4 ]
机构
[1] Mansoura Univ, Fac Med, Ophthalmol Ctr, Mansoura, Egypt
[2] Benha Univ, Fac Med, Ophthalmol Dept, Banha, Egypt
[3] Mansoura Univ, Fac Med, Dept Biochem Med, Mansoura, Egypt
[4] Mansoura Univ, Fac Med, Dept Clin Pathol, Mansoura, Egypt
关键词
5-HT; 5-HIAA; aqueous humor; glaucoma; cataract;
D O I
10.1556/IMAS.3.2011.2.3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To investigate the levels of 5-HT (serotonin, 5-hydroxytryptamine) and 5-HIAA (5-hydroxyindolacetic acid) in the aqueous humor and plasma of subjects with primary open-angle glaucoma (POAG) and to correlate their concentrations with the severity of glaucoma. Methods: Thirty-five patients with POAG and 30 patients with senile cataract (control group) of matched age and gender were included in the study prospectively. Aqueous humor samples were obtained by paracentesis from glaucoma and cataract patients who were undergoing elective surgery. Aqueous humor and corresponding plasma samples were analyzed for 5-HT and 5-HIAA levels by high performance liquid chromatography with electrochemical detection. Results: 5-HT and 5-HIAA levels were significantly higher in the aqueous humor of POAG patients than in that of the comparative group of cataract patients. There was no significant difference in the 5-HT and 5-HIAA levels in plasma of POAG and cataract patients. A positive correlation was found between 5-HT and 5-HIAA in the aqueous humor of POAG patients. The 5-HT turnover (5-HIAA/5-HT) was higher in POAG than in cataract patients, but the difference was not significant. No significant correlation was found between levels and severity of visual field loss. Conclusion: Increased levels of 5-HT and 5-HIAA aqueous humor may be associated with POAG.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 25 条
  • [1] ALI SF, 1993, NEUROTOXICOLOGY, V14, P29
  • [2] Choi SI, 2008, J PINEAL RES, V44, P95
  • [3] SSRIs and intraocular pressure modifications - Evidence, therapeutic implications and possible mechanisms
    Costagliola, C
    Parmeggiani, F
    Sebastiani, A
    [J]. CNS DRUGS, 2004, 18 (08) : 475 - 484
  • [4] Gene mapping for primary open angle glaucoma
    Fan, BJ
    Wang, DY
    Lam, DSC
    Pang, CP
    [J]. CLINICAL BIOCHEMISTRY, 2006, 39 (03) : 249 - 258
  • [5] Gallego-Pinazo R., 2008, Arch Soc Esp Oftalmol, V83, P105
  • [6] Oxidative Stress Markers in Patients with Primary Open-Angle Glaucoma
    Ghanem, Asaad A.
    Arafa, Lamiaa F.
    El-Baz, Ayman
    [J]. CURRENT EYE RESEARCH, 2010, 35 (04) : 295 - 301
  • [7] Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo
    Guo, L
    Salt, TE
    Maass, A
    Luong, V
    Moss, SE
    Fitzke, FW
    Cordeiro, MF
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (02) : 626 - 633
  • [8] Should we treat the brain in glaucoma?
    Gupta, Neeru
    Yucel, Yeni H.
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (03): : 409 - 413
  • [9] Haleng J, 2007, Rev Med Liege, V62, P628
  • [10] Hernandez-Saavedra Daniel, 2007, Rev Med Inst Mex Seguro Soc, V45, P477